CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Albuterol Sulfate

· ingredient albuterolSelective beta-2-adrenoreceptor agonists· ALBUTEROL SULFATE 2 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.03508
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other albuterol products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
albuterol sulfate$0.06535+$0.03030
Ipratropium Bromide and Albuterol Sulfate$0.08739+$0.05230
Albuterol Sulfate Inhalation Solution$0.22472+$0.18960
Albuterol$0.32659+$0.29150
Albuterol Sulfate Inhalation Solution, 0.5%$0.51281+$0.47770
Albuterol Sulfate HFA$1.65+$1.62
Albuterol$1.82+$1.79
albuterol sulfate$2.14+$2.11

Medicare Part D coverage · CY2026

On 272 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 1% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.